SO
KYTH

STRS Ohio’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

STRS Ohio’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,492
Closed -$49K – 1883
2014
Q3 		$49K Sell
1,492
-4,508
-75% -$159K ﹤0.01% 1652
2014
Q2 		$230K Sell
6,000
-13,300
-69% -$464K ﹤0.01% 1431
2014
Q1 		$767K Buy
19,300
+13,500
+233% +$604K ﹤0.01% 894
2013
Q4 		$216K Buy
+5,800
New +$241K ﹤0.01% 1440

Other funds holding KYTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return

STRS Ohio's KYTH Position: Q4 2014 in Review

STRS Ohio sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2014, closing a stake of 1,492 shares — an estimated $49K sold.

STRS Ohio first reported a position in KYTH in Q4 2013 and held it in 4 quarters. The position peaked at $767K in Q1 2014. 106 funds tracked by Wall St. Rank hold KYTH as of Q4 2014.

  • STRS Ohio reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2014 after selling out during the quarter.
  • STRS Ohio sold 1,492 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2014, an estimated $49K.
  • STRS Ohio first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q4 2013 and held it in 4 quarters.
  • STRS Ohio's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $767K in Q1 2014.
  • 106 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2014.

Based on STRS Ohio's 13F filing for Q4 2014, filed 23 Jan 2015.